• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation.接受阿司匹林和抗凝剂联合治疗的患者对质子泵抑制剂处方的国家指南依从性较低。
Therap Adv Gastroenterol. 2017 May;10(5):387-396. doi: 10.1177/1756283X17694807. Epub 2017 Mar 26.
2
Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.质子泵抑制剂用于预防医院获得性上消化道出血:标准化指南对处方实践的影响。
Arch Intern Med. 2010 May 10;170(9):779-83. doi: 10.1001/archinternmed.2010.51.
3
Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.卡塔尔急性冠状动脉综合征患者中质子泵抑制剂与双重抗血小板治疗的联合处方情况。
Int J Clin Pharm. 2016 Apr;38(2):353-61. doi: 10.1007/s11096-016-0250-4. Epub 2016 Jan 9.
4
Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge.入院和出院时质子泵抑制剂的处方模式
GE Port J Gastroenterol. 2019 Mar;26(2):114-120. doi: 10.1159/000488506. Epub 2018 May 2.
5
Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.西班牙一家三级医院中患者在入院时、治疗期间及出院时质子泵抑制剂的过度使用情况。
Curr Clin Pharmacol. 2010 Nov;5(4):288-97. doi: 10.2174/157488410793352067.
6
Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.低剂量乙酰水杨酸与胃肠道溃疡或出血——质子泵抑制剂使用模式影响的队列研究。
J Intern Med. 2013 Oct;274(4):371-80. doi: 10.1111/joim.12103. Epub 2013 Jul 10.
7
Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.英国初级保健中基线胃肠道风险和质子泵抑制剂使用对阿司匹林用于二级心血管预防的停药频率的影响。
Am J Cardiol. 2013 Oct 15;112(8):1075-82. doi: 10.1016/j.amjcard.2013.05.051. Epub 2013 Jul 4.
8
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.经皮冠状动脉介入治疗后使用质子泵抑制剂与药物洗脱支架的关系。
Am J Cardiol. 2010 Mar 15;105(6):833-8. doi: 10.1016/j.amjcard.2009.10.063.
9
Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.氯吡格雷和质子泵抑制剂与低剂量乙酰水杨酸联合用药的预测因素和时间趋势。
Pharmacoepidemiol Drug Saf. 2012 May;21(5):463-9. doi: 10.1002/pds.3195. Epub 2012 Feb 1.
10
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.阿司匹林和氯吡格雷联合或不联合质子泵抑制剂用于胃肠道出血高危患者的心血管事件二级预防的比较。
Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

引用本文的文献

1
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.达比加群双重治疗与华法林三联治疗在伴有/不伴有质子泵抑制剂的经皮冠状动脉介入治疗后心房颤动患者中的比较:RE-DUAL PCI 试验的预先指定分析。
Drugs. 2020 Jul;80(10):995-1005. doi: 10.1007/s40265-020-01323-x.

本文引用的文献

1
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.质子泵抑制剂在酸相关性疾病中的有效与安全治疗——一份探讨抑酸益处及潜在危害的立场文件
BMC Med. 2016 Nov 9;14(1):179. doi: 10.1186/s12916-016-0718-z.
2
Are proton pump inhibitors really so dangerous?质子泵抑制剂真的那么危险吗?
Dig Liver Dis. 2016 Aug;48(8):851-9. doi: 10.1016/j.dld.2016.05.018. Epub 2016 May 30.
3
Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.胃肠道出血患者用利伐沙班或华法林治疗:ROCKET AF 试验。
J Am Coll Cardiol. 2015 Dec 1;66(21):2271-2281. doi: 10.1016/j.jacc.2015.09.024.
4
Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.胃保护剂预防达比加群相关胃肠道出血的效果:一项基于人群的研究。
Gastroenterology. 2015 Sep;149(3):586-95.e3. doi: 10.1053/j.gastro.2015.05.002. Epub 2015 May 8.
5
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228. doi: 10.1016/j.jacc.2014.09.017. Epub 2014 Sep 23.
6
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17.
7
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2012年美国心脏病学会基金会/美国心脏协会实践指南工作组对不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南的聚焦更新(更新2007年指南并取代2011年聚焦更新):美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2012 Aug 14;126(7):875-910. doi: 10.1161/CIR.0b013e318256f1e0. Epub 2012 Jul 16.
8
Audit and feedback: effects on professional practice and healthcare outcomes.审核与反馈:对专业实践和医疗结果的影响。
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD000259. doi: 10.1002/14651858.CD000259.pub3.
9
Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital.西班牙一家三级医院中患者在入院时、治疗期间及出院时质子泵抑制剂的过度使用情况。
Curr Clin Pharmacol. 2010 Nov;5(4):288-97. doi: 10.2174/157488410793352067.
10
The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness.健康素养和书面药物信息在非甾体抗炎药风险意识中的作用。
Ann Pharmacother. 2010 Feb;44(2):274-84. doi: 10.1345/aph.1M479. Epub 2010 Jan 26.

接受阿司匹林和抗凝剂联合治疗的患者对质子泵抑制剂处方的国家指南依从性较低。

Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation.

作者信息

Sharma Rajani, Roy Abhik, Ramos Christopher, Rosenberg Richard, Garcia-Carrasquillo Reuben, Lebwohl Benjamin

机构信息

Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, NY, USA.

Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, 180 Fort Washington Avenue, Suite 936, New York, NY 10032, USA.

出版信息

Therap Adv Gastroenterol. 2017 May;10(5):387-396. doi: 10.1177/1756283X17694807. Epub 2017 Mar 26.

DOI:10.1177/1756283X17694807
PMID:28507597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5415095/
Abstract

BACKGROUND

Aspirin, when used with concurrent anticoagulation, increases the risk of gastrointestinal bleeding (GIB). Therefore, multisociety guidelines recommend prophylactic proton-pump inhibitors (PPIs) for patients receiving aspirin and anticoagulation. We aimed to determine rates and predictors of adherence to these recommendations.

METHODS

All adult inpatients discharged from the hospital on aspirin and anticoagulation from July 2009 to June 2014 were retrospectively evaluated for PPI prescription on discharge instructions. We used univariate and multivariate logistic regression to test for predictors of PPI prescription.

RESULTS

A total of 2422 patients were discharged on aspirin and anticoagulation; the mean age was 68 years and 53.2% were male; 42.2% were prescribed a PPI at discharge. On univariate analysis, factors associated with discharge PPI prescription included increased age (47.1% 37.9%), white race (47.3% 37.1-40.2%), higher aspirin dose (55.1% 39.4%), being married (46.2% 39.4%) and preadmission PPI use (96.6% 23.4%). On multivariate analysis, significant predictors of discharge PPI prescription were age 60-69 years [odds ratio (OR) 1.61] and 70-79 years (OR 1.48), and preadmission PPI use (OR 120.03). Lower odds of discharge PPI prescription included Medicaid (OR 0.55) or Medicare (OR 0.71) insurance, Spanish language (OR 0.63), and lower dose aspirin (81 mg) (OR 0.40).

CONCLUSIONS

A total of 42.2% of patients discharged on aspirin and anticoagulation were prescribed PPIs. Older age and preadmission PPI use were predictive of PPI prescription, while Medicaid/Medicare insurance, Spanish language, and lower dose aspirin decreased the likelihood of discharge PPI prescription. This creates an opportunity to improve primary GIB prevention through quality improvement interventions.

摘要

背景

阿司匹林与抗凝药同时使用时,会增加胃肠道出血(GIB)的风险。因此,多个学会的指南建议为接受阿司匹林和抗凝治疗的患者使用预防性质子泵抑制剂(PPI)。我们旨在确定遵循这些建议的比例及预测因素。

方法

对2009年7月至2014年6月期间从医院出院的所有服用阿司匹林并接受抗凝治疗的成年住院患者进行回顾性评估,以确定出院医嘱中是否开具了PPI。我们使用单因素和多因素逻辑回归来检验PPI处方的预测因素。

结果

共有2422例患者出院时服用阿司匹林并接受抗凝治疗;平均年龄为68岁,53.2%为男性;42.2%的患者出院时开具了PPI。单因素分析显示,与出院时开具PPI相关的因素包括年龄增加(47.1%对37.9%)、白人种族(47.3%对37.1%-40.2%)、阿司匹林剂量较高(55.1%对39.4%)、已婚(46.2%对39.4%)以及入院前使用PPI(96.6%对23.4%)。多因素分析显示,出院时开具PPI的显著预测因素为年龄60-69岁[比值比(OR)1.61]和70-79岁(OR 1.48),以及入院前使用PPI(OR 120.03)。出院时开具PPI的可能性较低的因素包括医疗补助(OR 0.55)或医疗保险(OR 0.71)参保、西班牙语(OR 0.63)以及低剂量阿司匹林(81毫克)(OR 0.40)。

结论

共有42.2%出院时服用阿司匹林并接受抗凝治疗的患者开具了PPI。年龄较大和入院前使用PPI可预测PPI处方,而医疗补助/医疗保险参保、西班牙语以及低剂量阿司匹林则降低了出院时开具PPI的可能性。这为通过质量改进干预措施改善原发性GIB预防创造了机会。